1
Vitreoretinal Sergeon, Feiz Ophthalmology Center, Isfahan University of Medical Sciences
2
Vitreoretinal Sergeon, Associate Professor of Ophthalmology, Farabi Ophthalmology Center, Isfahan University of Medical Sciences
3
Anterior Segment Sergeon, Associate Professor of Ophthalmology, Farabi Ophthalmology Center, Isfahan University of Medical Sciences
4
Optometrist, Ophthalmology Clinic
Abstract
In this paper, we present a case with acute vision loss due to ethambutol therapy. A sixty-three year-old man underwent tuberculosis treatment (Ethambutol, Izoniazid, Rifampicin, Pirazin Amid) six years before this report. Acute bilateral vision loss occurred three months later while receiving ethambutol treatment. Total vision loss in one eye, and partial vision loss in another eye and optic atrophy were found on physical and neurological examinations. Ethambutol is one of the major drugs in tuberculosis treatment. It is usually well tolerated; however an Important side effect of this drug is retro bulbar optic neuropathy, which should be considered. Background: Toxic optic neuropathy, optic Atrophy, tuberculosis, ethambutol Key words
Naderian,G. , Fesharaki,H. , Ghoraishi,M. and Sajjadi,V. (2007). A Case Report of Ethambutol Toxic Optic Atrophy. (e13219). Journal of Isfahan Medical School, 25(87), e13219
MLA
Naderian,G. , , Fesharaki,H. , , Ghoraishi,M. , and Sajjadi,V. . "A Case Report of Ethambutol Toxic Optic Atrophy" .e13219 , Journal of Isfahan Medical School, 25, 87, 2007, e13219.
HARVARD
Naderian G., Fesharaki H., Ghoraishi M., Sajjadi V. (2007). 'A Case Report of Ethambutol Toxic Optic Atrophy', Journal of Isfahan Medical School, 25(87), e13219.
CHICAGO
G. Naderian, H. Fesharaki, M. Ghoraishi and V. Sajjadi, "A Case Report of Ethambutol Toxic Optic Atrophy," Journal of Isfahan Medical School, 25 87 (2007): e13219,
VANCOUVER
Naderian G., Fesharaki H., Ghoraishi M., Sajjadi V. A Case Report of Ethambutol Toxic Optic Atrophy. JIMS, 2007; 25(87): e13219.
